Class information for:
Level 1: HIV DRUG RESISTANCE//HIV 1 DRUG RESISTANCE//TRANSMITTED DRUG RESISTANCE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
545 3324 35.0 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
29 3       HIV//VIROLOGY//HIV 1 108954
773 2             EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR 12242
545 1                   HIV DRUG RESISTANCE//HIV 1 DRUG RESISTANCE//TRANSMITTED DRUG RESISTANCE 3324

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HIV DRUG RESISTANCE authKW 338309 2% 53% 70
2 HIV 1 DRUG RESISTANCE authKW 323884 1% 77% 46
3 TRANSMITTED DRUG RESISTANCE authKW 315208 1% 76% 45
4 ANTIVIRAL THERAPY journal 216224 6% 11% 210
5 K65R authKW 200272 1% 84% 26
6 DRUG RESISTANCE authKW 159078 12% 4% 408
7 HIV 1 authKW 149568 11% 4% 369
8 ANTIRETROVIRAL DRUG RESISTANCE authKW 147169 1% 64% 25
9 DRUG RESISTANCE MUTATIONS authKW 130888 1% 49% 29
10 AIDS RESEARCH AND HUMAN RETROVIRUSES journal 128922 8% 5% 274

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Infectious Diseases 128777 58% 1% 1934
2 Virology 115795 45% 1% 1487
3 Immunology 22602 40% 0% 1324
4 Microbiology 10713 24% 0% 813
5 Pharmacology & Pharmacy 3142 20% 0% 660
6 Mathematical & Computational Biology 237 2% 0% 62
7 Biochemical Research Methods 166 3% 0% 111
8 Biotechnology & Applied Microbiology 72 4% 0% 118
9 Medicine, General & Internal 67 4% 0% 130
10 Tropical Medicine 53 1% 0% 27

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AIDS 122886 8% 5% 257
2 PHARMACCESS FDN 81685 0% 68% 13
3 EA 2968 69137 0% 47% 16
4 VIROL 68189 15% 2% 497
5 INT CLIN VIROL 61731 0% 61% 11
6 RETROVIROL 56515 2% 8% 73
7 INFECT DIS 49793 19% 1% 647
8 PHARMACCESS FDN GLOBAL HLTH 47233 0% 86% 6
9 VIROL IMMUNOL BIOL 43753 0% 53% 9
10 SECT RETROVIRAL THER EUT 42484 1% 26% 18

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIVIRAL THERAPY 216224 6% 11% 210
2 AIDS RESEARCH AND HUMAN RETROVIRUSES 128922 8% 5% 274
3 AIDS 92131 9% 3% 294
4 JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 49511 5% 4% 151
5 AIDS REVIEWS 27833 1% 10% 29
6 HIV MEDICINE 16961 1% 4% 45
7 JOURNAL OF CLINICAL VIROLOGY 12969 2% 2% 69
8 JOURNAL OF INFECTIOUS DISEASES 12175 5% 1% 154
9 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 10367 5% 1% 165
10 JOURNAL OF MEDICAL VIROLOGY 10309 3% 1% 93

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 HIV DRUG RESISTANCE 338309 2% 53% 70 Search HIV+DRUG+RESISTANCE Search HIV+DRUG+RESISTANCE
2 HIV 1 DRUG RESISTANCE 323884 1% 77% 46 Search HIV+1+DRUG+RESISTANCE Search HIV+1+DRUG+RESISTANCE
3 TRANSMITTED DRUG RESISTANCE 315208 1% 76% 45 Search TRANSMITTED+DRUG+RESISTANCE Search TRANSMITTED+DRUG+RESISTANCE
4 K65R 200272 1% 84% 26 Search K65R Search K65R
5 DRUG RESISTANCE 159078 12% 4% 408 Search DRUG+RESISTANCE Search DRUG+RESISTANCE
6 HIV 1 149568 11% 4% 369 Search HIV+1 Search HIV+1
7 ANTIRETROVIRAL DRUG RESISTANCE 147169 1% 64% 25 Search ANTIRETROVIRAL+DRUG+RESISTANCE Search ANTIRETROVIRAL+DRUG+RESISTANCE
8 DRUG RESISTANCE MUTATIONS 130888 1% 49% 29 Search DRUG+RESISTANCE+MUTATIONS Search DRUG+RESISTANCE+MUTATIONS
9 RESISTANCE MUTATIONS 128713 1% 37% 38 Search RESISTANCE+MUTATIONS Search RESISTANCE+MUTATIONS
10 MINORITY VARIANTS 119021 1% 72% 18 Search MINORITY+VARIANTS Search MINORITY+VARIANTS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 FRENTZ, D , BOUCHER, CAB , VAN DE VIJVER, DAMC , (2012) TEMPORAL CHANGES IN THE EPIDEMIOLOGY OF TRANSMISSION OF DRUG-RESISTANT HIV-1 ACROSS THE WORLD.AIDS REVIEWS. VOL. 14. ISSUE 1. P. 17 -27 170 79% 77
2 SHAFER, RW , (2002) GENOTYPIC TESTING FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 DRUG RESISTANCE.CLINICAL MICROBIOLOGY REVIEWS. VOL. 15. ISSUE 2. P. 247 -+ 217 62% 185
3 SHAFER, RW , SCHAPIRO, JM , (2008) HIV-1 DRUG RESISTANCE MUTATIONS: AN UPDATED FRAMEWORK FOR THE SECOND DECADE OF HAART.AIDS REVIEWS. VOL. 10. ISSUE 2. P. 67 -84 162 58% 166
4 MARTINEZ-PICADO, J , MARTINEZ, MA , (2008) HIV-1 REVERSE TRANSCRIPTASE INHIBITOR RESISTANCE MUTATIONS AND FITNESS: A VIEW FROM THE CLINIC AND EX VIVO.VIRUS RESEARCH. VOL. 134. ISSUE 1-2. P. 104-123 126 76% 89
5 HIRSCH, MS , GUNTHARD, HF , SCHAPIRO, JM , BRUN-VEZINET, F , CLOTET, B , HAMMER, SM , JOHNSON, VA , KURITZKES, DR , MELLORS, JW , PILLAY, D , ET AL (2008) ANTIRETROVIRAL DRUG RESISTANCE TESTING IN ADULT HIV-1 INFECTION: 2008 RECOMMENDATIONS OF AN INTERNATIONAL AIDS SOCIETY-USA PANEL.CLINICAL INFECTIOUS DISEASES. VOL. 47. ISSUE 2. P. 266 -285 114 66% 239
6 VANDAMME, AM , CAMACHO, RJ , CECCHERINI-SILBERSTEIN, F , DE LUCA, A , PALMISANO, L , PARASKEVIS, D , PAREDES, R , POLJAK, M , SCHMIT, JC , SORIANO, V , ET AL (2011) EUROPEAN RECOMMENDATIONS FOR THE CLINICAL USE OF HIV DRUG RESISTANCE TESTING: 2011 UPDATE.AIDS REVIEWS. VOL. 13. ISSUE 2. P. 77 -108 140 58% 62
7 MENENDEZ-ARIAS, L , (2008) MECHANISMS OF RESISTANCE TO NUCLEOSIDE ANALOGUE INHIBITORS OF HIV-1 REVERSE TRANSCRIPTASE.VIRUS RESEARCH. VOL. 134. ISSUE 1-2. P. 124-146 142 64% 55
8 PAREDES, R , CLOTET, B , (2010) CLINICAL MANAGEMENT OF HIV-1 RESISTANCE.ANTIVIRAL RESEARCH. VOL. 85. ISSUE 1. P. 245-265 112 69% 41
9 CLUTTER, DS , JORDAN, MR , BERTAGNOLIO, S , SHAFER, RW , (2016) HIV-1 DRUG RESISTANCE AND RESISTANCE TESTING.INFECTION GENETICS AND EVOLUTION. VOL. 46. ISSUE . P. 292 -307 115 60% 1
10 SNEDECOR, SJ , SUDHARSHAN, L , NEDROW, K , BHANEGAONKAR, A , SIMPSON, KN , HAIDER, S , CHAMBERS, R , CRAIG, C , STEPHENS, J , (2014) BURDEN OF NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RESISTANCE IN HIV-1-INFECTED PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.AIDS RESEARCH AND HUMAN RETROVIRUSES. VOL. 30. ISSUE 8. P. 753 -768 97 75% 7

Classes with closest relation at Level 1


Rank Class id link
1 1588 AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 SUBTYPES//CIRCULATING RECOMBINANT FORMS
2 7021 RALTEGRAVIR//DOLUTEGRAVIR//ETRAVIRINE
3 2716 ANTIRETROVIRAL THERAPY//ROYAL FREE HIV MED//CD4 CELL COUNT
4 1509 NNRTIS//REVERSE TRANSCRIPTASE//HIV 1 REVERSE TRANSCRIPTASE
5 6181 ATAZANAVIR//RITONAVIR//LOPINAVIR
6 13589 DRIED BLOOD SPOTS//VIRAL LOAD//HCV RNA STABILITY
7 2183 HIV 1 PROTEASE//HIV PROTEASE//HIV 1 PROTEASE INHIBITORS
8 5405 ZIDOVUDINE//DIDANOSINE//ZALCITABINE
9 3091 LOSS TO FOLLOW UP//ANTIRETROVIRAL THERAPY//HLTH ECON EPIDEMIOL OFF
10 4819 PEDIATRIC HIV//EARLY INFANT DIAGNOSIS//EMPILWENI SERV UNIT

Go to start page